Li Kang Biomedical Co., Ltd. (6242)
Market Closed
16 Oct, 05:30 AM
TWSE TWSE Primary NT$
34. 00
+0.3
+0.8902%
NT$
1.4B Market Cap
- P/E Ratio
10% Div Yield
10,882 Volume
- Eps
NT$ 33.7
Previous Close Want to track 6242 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Li Kang Biomedical Co., Ltd. (6242) Statistics
Valuation metrics
Market Cap 1.4B
Enterprise value 1.18B
Trailing P/E (ttm) 14.05
Forward P/E -
PEG ratio -1.31
Price/Sales (ttm) 1.88
Price/Book (mrq) 1.27
Enterprise Value/Revenue 2.05
Enterprise Value/EBITDA 12.73
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.57K
Average volume (90 days) 4.28K
Price summary
52-Week low 33.6
52-Week high 41.4
Beta -
50-Day moving average 33.96
200-Day moving average 36.14
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 2
Trailing annual dividend yield 0.0591%
5-Year annual dividend yield -
Payout ratio 0.83
Dividend Date 22 Jul 2026
Ex-Dividend Date 16 Jun 2026
Last split factor 517:500
Last split Date 27 Dec 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.13%
Operating margin 0.15%
Operational effectiveness
Return on assets 0.07%
Return on equity 0.09%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 18.11
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 2.41
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 5.63
Total debt (mrq) -
Total Debt/Equity (mrq) 0.19
Current ratio (mrq) 1.04%
Book value per share (mrq) 26.62
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
